Phlow Raises $20M in Series A Financing

16 Feb, 2021

Phlow Raises $20M in Series A Financing
Photo by Alex wong on Unsplash

– Phlow Corp., a public benefit corporation providing access to essential medicines, closed a $20m Series A funding.
– The company intends to use the funds to build its commercial business team, establish its commercial business unit’s data and analytics platforms, advance the commercial research and development of APIs and finished pharmaceutical products, and fund innovative initiatives to improve the delivery of essential medicines.
– Led by Eric Edwards, M.D., Ph.D., co-founder, president and CEO, Phlow is using advanced manufacturing processes leveraging flow chemistry to produce active pharmaceutical ingredients (APIs) and finished pharmaceutical products.

Chemical Manufacturing North America Pharmaceutical
Crunchbase icon

Content report

The following text will be sent to our editors: